The global “Connected Drug Delivery Devices Market Size” is projected to reach USD 4,062.7 million by 2026, exhibiting a CAGR of 35.4% during the forecast period. However, the market size was USD 361.1 million in 2018. This information is published in a recent report by Fortune Business Insights, titled, “Connected Drug Delivery Devices Market Size, Share & Industry Analysis, By Type (Injectable Devices and Inhalation Devices & Others) By Technology (Bluetooth, NFC, and Others) By End User (Homecare Settings and Hospitals) and Regional Forecast, 2019-2026.” As per the report, a rising incidence of diabetes, COPD, and asthma are anticipated to boost the connected drug delivery devices market growth in the coming years.
Key Companies and Manufacturers Covered:
The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight.
- Proteus Digital Health
- Cohero Health, Inc.
- Hoffmann-La Roche Ltd.
- West Pharmaceutical Services
- Ypsomed Holding
- Propeller Health (A ResMed Company)
- Detailed Historical Overview
- Consumer and Pricing Analysis
- Market Dynamics of the Industry
- In-depth Market Segmentation
- Historical and Projected Market Sizing in Terms of Value
- Recent Market Trends and Impact Factors
- R&D Status and Technology Overview
- Extensive Industry Structure Coverage
Increasing Demand for Digital Medical Devices to Favor Growth in Europe
North America had generated USD 253.0 million connected drug delivery devices market revenue in 2018. The region is anticipated to lead the market throughout the forthcoming years. Strategic collaborations, existence of major players, increasing healthcare expenditure, and well-established infrastructure are some of the most significant drivers of the market in this region. Europe is experiencing a rising demand for digital medical devices as well as a higher adoption of connected drug delivery devices on account of an urgent requirement to improve the patient experience.
Asia Pacific is showcasing a rise in the number of awareness programs regarding the cost benefits of connected drug delivery devices. It is also exhibiting an increasing adoption of innovative medical technology. These factors are set to create high growth opportunities.
More Trending Topics from Fortune Business Insights: